Sassine A, Brugada J, Munoz A, Romero-Ayala L, Masse C
Drugs Exp Clin Res. 1987;13(1):15-20.
The cardiac electrophysiological effects of Penticainide, a new antiarrhythmic agent, were studied by means of intracardiac electrodes in the anaesthetized dog. Intravenous administration of 5 mg/kg of Penticainide reduced the sinus rate and prolonged the sinus node recovery time. Atrial refractory periods increased. Anterograde intranodal conduction slowed and nodal refractoriness increased. Conduction time in the His-Purkinje tissue and ventricle increased, as did the ventricular refractory periods. Monophasic action potential duration was not altered by the drug in the atrium or the ventricle. The mechanism of action of Penticainide as an antiarrhythmic drug seems to be correlated to its membrane effects: inhibition of the fast-inward current, responsible for the marked effects on His-Purkinje and ventricular tissues; and inhibition of the slow-inward current, suggested by its effects on sinus node and atrio-ventricular node.
采用心内电极法,在麻醉犬身上研究了新型抗心律失常药物喷替卡因的心脏电生理效应。静脉注射5mg/kg喷替卡因可降低窦性心率,延长窦房结恢复时间。心房不应期延长。房室结前向传导减慢,结区不应期延长。希氏-浦肯野组织和心室的传导时间增加,心室不应期也增加。药物对心房或心室的单相动作电位时程无影响。喷替卡因作为抗心律失常药物的作用机制似乎与其膜效应有关:抑制快内向电流,这是其对希氏-浦肯野组织和心室组织产生显著效应的原因;抑制慢内向电流,这是由其对窦房结和房室结的作用所提示的。